University of California San Francisco General Hospital
Welcome,         Profile    Billing    Logout  
 4 Trials 
16 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chen, Peter V
DEBRA, NCT04852887: De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer

Recruiting
3
1670
Canada, Japan, US, RoW
Radiation and Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane), Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane)
NRG Oncology, National Cancer Institute (NCI)
Stage I Breast Cancer
01/26
07/41
HERO, NCT05705401: Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer

Recruiting
3
1300
US
Standard of Care Adjuvant Breast Radiation, Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation
NRG Oncology, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, Eastern Cooperative Oncology Group, SWOG Cancer Research Network
HER2-positive Breast Cancer
02/34
02/37
NECTAR, NCT04924660: Novel Experimental COVID-19 Therapies Affecting Host Response

Completed
2/3
871
US
TXA127, TRV027, Placebo, Fostamatinib
Sean Collins, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
COVID-19, SARS-CoV-2 Infection, Coronavirus Infection
10/23
12/23
RECOVER-AUTO, NCT06305780: NOMIC Platform Protocol

Recruiting
2
380
US
IVIG + Coordinated Care, IVIG Placebo + Coordinated Care, Ivabradine + Coordinated Care, Ivabradine Placebo + Coordinated Care, IVIG + Usual Care, IVIG Placebo + Usual Care, Ivabradine + Usual Care, Ivabradine Placebo + Usual Care
Kanecia Obie Zimmerman
Long COVID, Long Covid19, Long Covid-19
12/25
03/26
RECOVER-VITAL, NCT05595369: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

Active, not recruiting
2
964
US
Experimental: Paxlovid 25 day dosing, Experimental: Paxlovid 15 day dosing, Placebo Comparator: Control
Kanecia Obie Zimmerman
Long COVID, Long Covid19
08/24
03/25
IORT, NCT01189851: Intraoperative Radiotherapy for Early Stage Breast Cancer

Completed
N/A
200
US
Intraoperative Radiotherapy, 510(k) Number K050843, Axxent™ Electronic Brachytherapy System
Hoag Memorial Hospital Presbyterian
Breast Cancer
09/23
12/23
CATHAY, NCT05562622: Assessment of DOT Spectacles in Chinese Children

Active, not recruiting
N/A
195
RoW
Novel spectacle lens design, Spectacle lenses
SightGlass Vision, Inc.
Juvenile Myopia, Myopia
09/25
03/26
NCT05172024: Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

Active, not recruiting
N/A
15178
US
NYU Langone Health, National Heart, Lung, and Blood Institute (NHLBI)
SARS-CoV2 Infection
04/25
05/25
PREDICT, NCT03448926: The Registry:

Recruiting
N/A
3000
US
Treatment Recommendation Surveys, 7-gene biosignature
PreludeDx, University of South Florida
DCIS
12/25
12/35
Thomas, Robert
NCT05837091: Low Sodium Oxybate in Patients With Idiopathic Hypersomnia

Recruiting
4
30
US
Low Sodium Oxybate, Xywav, Calcium, Magnesium, Potassium, and Sodium Oxybates, 24-hour polysomnography, Nextsense EEG earbuds, Axivity device
Mayo Clinic
Idiopathic Hypersomnia
06/25
06/25
NCT05156047: A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia

Completed
3
214
US
Open-label pitolisant, Double-blind placebo, Double-blind pitolisant
Harmony Biosciences, LLC
Idiopathic Hypersomnia
09/23
09/23
NCT05668754: Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH

Completed
2
50
US
Serdexmethylphenidate, SDX, Placebo
Zevra Therapeutics, Rho, Inc.
Idiopathic Hypersomnia
02/24
03/24
NCT06404086: RECOVER-SLEEP: Platform Protocol

Recruiting
2
1074
US
Modafinil, Modafinil Placebo, Solriamfetol, Solriamfetol Placebo, Melatonin, Melantonin Placebo, Tailored lighting (TL) Active, Tailored lighting (TL) Placebo
Duke University
Long COVID, Long COVID-19, Hypersomnia, Sleep Disturbance
07/25
07/25
MIND-P, NCT04647474: Mental Wellbeing and Quality of Life in Prostate Cancer

Completed
N/A
300
Europe
King's College London, King's College Hospital NHS Trust, Guy's and St Thomas' NHS Foundation Trust, Imperial College Healthcare NHS Trust, Medway NHS Foundation Trust, Lewisham and Greenwich NHS Trust, Surrey and Sussex Healthcare NHS Trust, Bedfordshire Hospitals NHS Foundation Trust
Prostate Cancer
03/23
03/23
THRIVE, NCT06076499: A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS

Recruiting
N/A
325
US
NTX100
Noctrix Health, Inc.
Restless Legs Syndrome
06/25
12/26
Wear WOLF, NCT06727071: Using Wearable Sensors To Understand Low Blood Sugar in Type 1 Diabetes

Not yet recruiting
N/A
20
US
Hyperglycemic clamp
University of California, San Diego, National Institutes of Health (NIH)
Type 1 Diabetes Mellitus
03/26
06/26

Download Options